Schrum Private Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,260
Closed -$406K 125
2024
Q3
$406K Buy
1,260
+370
+42% +$121K 0.21% 109
2024
Q2
$278K Hold
890
0.25% 99
2024
Q1
$253K Buy
890
+80
+10% +$23.4K 0.23% 109
2023
Q4
$233K Sell
810
-80
-9% -$21.8K 0.33% 84
2023
Q3
$239K Buy
+890
New +$222K 0.27% 96
2023
Q2
Sell
-890
Closed -$215K 110
2023
Q1
$215K Buy
890
+73
+9% +$17.9K 0.25% 102
2022
Q4
$215K Buy
+817
New +$219K 0.25% 104
2022
Q2
Sell
-817
Closed -$203K 114
2022
Q1
$203K Buy
+817
New +$188K 0.2% 117

Other funds holding AMGN

Schrum Private Wealth Management's AMGN Position: Q4 2024 in Review

Schrum Private Wealth Management sold out of Amgen (AMGN) in Q4 2024, closing a stake of 1,260 shares — an estimated $406K sold.

Schrum Private Wealth Management first reported a position in AMGN in Q1 2022 and held it in 8 quarters. The position peaked at $406K in Q3 2024. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • Schrum Private Wealth Management reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
  • Schrum Private Wealth Management sold 1,260 Amgen shares in Q4 2024, an estimated $406K.
  • Schrum Private Wealth Management first reported a position in Amgen in Q1 2022 and held it in 8 quarters.
  • Schrum Private Wealth Management's Amgen position peaked at $406K in Q3 2024.
  • 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Schrum Private Wealth Management's 13F filing for Q4 2024, filed 7 Feb 2025.